日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression

PKA驱动的SPP1激活是连接骨微环境与前列腺癌进展的一种新机制

Sanchis, Pablo; Sabater, Agustina; Lechuga, Julia; Rada, Jimena; Seniuk, Rocio; Pascual, Gaston; Gatti, Mora; Bizzotto, Juan; Shepherd, Peter D A; Yang, Jun; Cotignola, Javier; Vazquez, Elba; Mateo, Joaquin; Valacco, Pia; Labanca, Estefania; Logothetis, Christopher; Gueron, Geraldine; Anselmino, Nicolas

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

成纤维细胞生长因子受体 1 驱动前列腺癌的转移进展

Labanca Estefania, Yang Jun, Shepherd Peter D A, Wan Xinhai, Starbuck Michael W, Guerra Leah D, Anselmino Nicolas, Bizzotto Juan A, Dong Jiabin, Chinnaiyan Arul M, Ravoori Murali K, Kundra Vikas, Broom Bradley M, Corn Paul G, Troncoso Patricia, Gueron Geraldine, Logothethis Christopher J, Navone Nora M

Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells

骨祖细胞在早期前列腺癌细胞代谢重编程中起着关键作用

Sanchis, Pablo; Anselmino, Nicolas; Lage-Vickers, Sofia; Sabater, Agustina; Lavignolle, Rosario; Labanca, Estefania; Shepherd, Peter D A; Bizzotto, Juan; Toro, Ayelen; Mitrofanova, Antonina; Valacco, Maria Pia; Navone, Nora; Vazquez, Elba; Cotignola, Javier; Gueron, Geraldine

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

MD安德森前列腺癌患者来源异种移植模型系列(MDA PCa PDX)能够捕捉前列腺癌的分子特征,并促进基于分子标志物的治疗研发。

Palanisamy, Nallasivam; Yang, Jun; Shepherd, Peter D A; Li-Ning-Tapia, Elsa M; Labanca, Estefania; Manyam, Ganiraju C; Ravoori, Murali K; Kundra, Vikas; Araujo, John C; Efstathiou, Eleni; Pisters, Louis L; Wan, Xinhai; Wang, Xuemei; Vazquez, Elba S; Aparicio, Ana M; Carskadon, Shannon L; Tomlins, Scott A; Kunju, Lakshmi P; Chinnaiyan, Arul M; Broom, Bradley M; Logothetis, Christopher J; Troncoso, Patricia; Navone, Nora M